Q32 Bio Inc.

Healthcare

NASDAQ:QTTB · NASDAQ Global Market

Market Cap $152.04M Beta -0.23 P/E (TTM) 5.4

$11.90 -1.70%

-$0.22 today

52W Low $1.35High $14.85

Vol 0.41M · Avg 0.74M

EPS (TTM) $2.36Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+677.78%

Period High

$14.00

Period Low

$1.36

Latest

$11.90

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

AN2 Therapeutics, Inc.

NASDAQ:ANTX

$135.09M

Verrica Pharmaceuticals Inc.

NASDAQ:VRCA

$63.17M

SAB Biotherapeutics, Inc.

SABS

$37.95M

Generation Bio Co.

GBIO

$35.98M

Boundless Bio, Inc.

BOLD

$32.01M

Plus Therapeutics, Inc.

PSTV

$10.16M

Sonnet BioTherapeutics Holdings, Inc.

SONN

$8.43M

Intensity Therapeutics, Inc.

INTS

$7.04M

NextCure, Inc.

NXTC

$5.49M

Iterum Therapeutics plc

ITRM

$1.60M

What is the latest QTTB filing?

The latest filing shown is 4 dated Jun 16, 2026.

How many recent filings does QTTB have?

Intrinsic Alpha currently shows 20 recent filings for QTTB.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.